The story of Viagra, and its parent company copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in sales , its patent expiration created a deluge of lower-priced alternatives , significantly diminishing its position . While some businesses may try to capitalize on similar conditions , the present l